✦ LIBER ✦

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure

✍ Scribed by J. F. W. Hoogkamer; C. H. Kleinbloesem; A. Nokhodian; M. J. A. Ouwerkerk; G. Lankhaar; W. Ungethüm; W. Kirch

Publisher: Springer
Year: 1998
Tongue: English
Weight: 263 KB
Volume: 54
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050421

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of imidapril and its ac

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function

✍ J. F. W. Hoogkamer; C. H. Kleinbloesem; A. Nokhodian; M. J. A. Ouwerkerk; G. Lan 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 108 KB

Pharmacokinetics of oral diltiazem and f

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)

Pharmacokinetics of intravenous diltiaze

Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers

✍ Maha Tawashi; Julien Marc-aurèle; Daniel Bichet; Jean Spénard; Lyne Larivière; D 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

The pharmacokinetics of diltiazem were studied in seven patients with chronic renal failure (CRF) not requiring dialysis and in three healthy volunteers after a rapid i.v. infusion of 20mg. Mean plasma concentrations at the end of infusion were 3.15 times higher in patients with CRF than in healthy

Plasma concentrations and pharmacokineti

Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy

✍ P. Pisano; A. Durand; E. Autret; C. Desnuelle; N. Pinsard; G. Serratrice; V. Leg 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 47 KB

The pharmacokinetics of carvedilol and i

The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency

✍ T. W. B. Gehr; D. M. Tenero; D. A. Boyle; Y. Qian; D. A. Sica; N. H. Shusterman 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 152 KB

The disposition of paracetamol and the a

The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure

✍ U. Martin; R. M. Temple; R. J. Winney; L. F. Prescott 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 385 KB

We have compared the disposition of oral paracetamol (1.0 g t.d.s. for 10 days) in 6 healthy volunteers and 6 conservatively-managed patients with chronic renal failure (mean plasma creatinine 451 mumol.l-1). Blood was sampled daily for 10 days before the morning dose of paracetamol. Each day the pr